Type I interferon inhibits varicella-zoster virus replication by interfering with the dynamic interaction between mediator and IE62 within replication compartments
Open Access
- 16 March 2016
- journal article
- research article
- Published by Springer Nature in Cell & Bioscience
- Vol. 6 (1) , 1-12
Abstract
Varicella-zoster virus (VZV) is the causative agent of varicella and zoster. The immediate-early protein, IE62 is the predominant VZ virion tegument protein, transactivating the expression of all kinetic classes of VZV genes. IE62 is localized to punctae that form DNA replication compartments in the nuclei of VZV infected cells. The morphological changes and the increase in the size of replication compartments that express IE62 are correlated with production of VZ virions. Mammalian Mediator serves as a coactivator of IE62 and functions by bridging DNA-binding transcription factors¸ RNA polymerase II (RNAP II) and their target DNAs for VZV replication. While VZV is highly sensitive to type I interferons (IFNs), how IFN-α inhibits early events during VZV replication is poorly understood. In this study, we performed in situ analysis to investigate the effects of IFN-α on the dynamic interactions of IE62 with the Mediator MED25 subunit and the RNAP II negative regulator cycle-dependent kinase 8 (CDK8) in VZV infected cells by confocal immunofluorescence. We found that in addition to dose-dependent inhibition of the yields of infectious virus by IFN treatment, IFN-α prominently impeded the development of large IE62+ nuclear compartments and significantly decreased transcription of VZV genes. Both the expression level and stable recruitment of MED25 to IE62+ replication compartments were inhibited by IFN-α. While IFN-α treatment upregulated CDK8 expression, redistribution and recruitment of CDK8 to IE62+ replication compartments in infected cells was not affected by VZV. IFN-α exerts multiple inhibitory activities against virus infections. In this study, we provide visionary demonstration that continuous translocation of MED25 into VZV replication compartments ensures production of virions. IFN-α greatly impedes the formation of a stable complex between IE62 and the Mediator complex thereby suppresses VZV gene transcription. Our demonstration that IFN-α-induced antiviral effect against VZV infection is through inhibiting the reorganization of nuclear components uncovers a novel function of IFN-α. Targeting the interaction between IE62 and MED25 may offer a novel approach to the development of antiviral agents against VZV infection.Keywords
Funding Information
- Ministry of Science and Technology, Taiwan (104-2320-B-002-048)
- National Science Council (97-2320-B-002-005-MY3, 99-3112-B-002-022)
This publication has 29 references indexed in Scilit:
- CDK8 Kinase Phosphorylates Transcription Factor STAT1 to Selectively Regulate the Interferon ResponseImmunity, 2013
- Interferon-stimulated genes and their antiviral effector functionsCurrent Opinion in Virology, 2011
- A diverse range of gene products are effectors of the type I interferon antiviral responseNature, 2011
- Varicella-Zoster Virus Immediate-Early Protein 62 Blocks Interferon Regulatory Factor 3 (IRF3) Phosphorylation at Key Serine Residues: a Novel Mechanism of IRF3 Inhibition among HerpesvirusesJournal of Virology, 2010
- Analysis of the Varicella-Zoster Virus IE62 N-Terminal Acidic Transactivating Domain and Its Interaction with the Human Mediator ComplexJournal of Virology, 2009
- The Replication Cycle of Varicella-Zoster Virus: Analysis of the Kinetics of Viral Protein Expression, Genome Synthesis, and Virion Assembly at the Single-Cell LevelJournal of Virology, 2009
- The human CDK8 subcomplex is a molecular switch that controls Mediator coactivator functionGenes & Development, 2009
- Varicella-Zoster Virus IE62 Protein Utilizes the Human Mediator Complex in Promoter ActivationJournal of Virology, 2008
- E2F1 represses β-catenin transcription and is antagonized by both pRB and CDK8Nature, 2008
- The cyclin-dependent kinase 8 module sterically blocks Mediator interactions with RNA polymerase IIProceedings of the National Academy of Sciences, 2006